A medium‐chain triglycerides‐enriched diet improves cognition and prevents metabolic and gut microbial alterations in Alzheimer’s disease models
Collectively, these findings reveal metabolism-improving benefits of MCT in the context of Alzheimer's disease that do not require elevated blood ketone levels and reveal potential therapeutic targets for treating AD, in the gut-brain axis.
Authors
- Karl J. L. Fernandes (ORCID: https://orcid.org/0000-0002-6236-8770)
- Éric Massé
- Anne Aumont
- Karine Prévost
- Paule E.H. M'Bra
- Laura K Hamilton
Institutions
- Université de Sherbrooke (CA)
- Q & T Research (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_103337
- Primary Topic
- Diet and metabolism studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00